Exact Mass: 1078.5394758

Exact Mass Matches: 1078.5394758

Found 80 metabolites which its exact mass value is equals to given mass value 1078.5394758, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Aculeacin A

Echinocandin B, 1-((4R,5R)-4,5-dihydroxy-N(sup 2)-(1-oxohexadecyl)-L-ornithine)-

C51H82N8O17 (1078.5797642)


A lipopeptide that is isolated from Aspergillus aculeatus and exhibits antifungal activity.

   

M-Secociguatoxin 4A

(29Z)-16-[(1Z)-buta-1,3-dien-1-yl]-45-(3-hydroxypropyl)-43,44,49,54,58-pentamethyl-2,7,11,17,21,26,33,37,41,46,51,57-dodecaoxadodecacyclo[30.28.0.0³,²⁷.0⁶,²⁵.0⁸,²².0¹⁰,²⁰.0¹²,¹⁸.0³⁴,⁵⁸.0³⁶,⁵⁶.0³⁸,⁵².0⁴⁰,⁵⁰.0⁴²,⁴⁷]hexaconta-4,14,23,29-tetraene-19,45,48,59-tetrol

C60H86O17 (1078.5864706)


M-Secociguatoxin 4A is found in fishes. M-Secociguatoxin 4A is isolated from Gambierdiscus toxicus.

   

Mcp-tva-argipressin

2-({1-[19-benzyl-13-(carbamoylmethyl)-22-[(4-ethoxyphenyl)methyl]-12,15,18,21,24-pentaoxo-16-(propan-2-yl)-7,8-dithia-11,14,17,20,23-pentaazaspiro[5.19]pentacosane-10-carbonyl]pyrrolidin-2-yl}formamido)-5-[(diaminomethylidene)amino]pentanamide

C51H74N12O10S2 (1078.5092024)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D014667 - Vasopressins D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

PIP(22:3(10Z,13Z,16Z)/PGE2)

{[(1S,6R,12Z,15R,18R,19S,20R,21R,22R,23S,24R)-3,18,20,22,23,24-hexahydroxy-19-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,8,16-trioxo-6-{[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]methyl}-2,4,7-trioxa-3lambda5-phosphabicyclo[13.6.3]tetracos-12-en-21-yl]oxy}phosphonic acid

C52H88O19P2 (1078.5394758)


PIP(22:3(10Z,13Z,16Z)/PGE2) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:3(10Z,13Z,16Z)/PGE2), in particular, consists of one chain of 10Z,13Z,16Z-docosenoyl at the C-1 position and one chain of Prostaglandin E2 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(PGE2/22:3(10Z,13Z,16Z))

{[(1S,6R,13Z,16R,19R,20S,21R,22R,23R,24S,25R)-3,19,21,23,24,25-hexahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,9,17-trioxo-6-[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]-2,4,8-trioxa-3lambda5-phosphabicyclo[14.6.3]pentacos-13-en-22-yl]oxy}phosphonic acid

C52H88O19P2 (1078.5394758)


PIP(PGE2/22:3(10Z,13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(PGE2/22:3(10Z,13Z,16Z)), in particular, consists of one chain of Prostaglandin E2 at the C-1 position and one chain of 10Z,13Z,16Z-docosenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:3(10Z,13Z,16Z)/PGD2)

{[(1S,6R,12Z,15S,16S,19R,20R,21R,22R,23S,24R)-3,16,20,22,23,24-hexahydroxy-19-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,8,18-trioxo-6-{[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]methyl}-2,4,7-trioxa-3lambda5-phosphabicyclo[13.6.3]tetracos-12-en-21-yl]oxy}phosphonic acid

C52H88O19P2 (1078.5394758)


PIP(22:3(10Z,13Z,16Z)/PGD2) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:3(10Z,13Z,16Z)/PGD2), in particular, consists of one chain of 10Z,13Z,16Z-docosenoyl at the C-1 position and one chain of Prostaglandin D2 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(PGD2/22:3(10Z,13Z,16Z))

{[(1S,6R,13Z,16S,17S,20R,21R,22R,23R,24S,25R)-3,17,21,23,24,25-hexahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,9,19-trioxo-6-[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]-2,4,8-trioxa-3lambda5-phosphabicyclo[14.6.3]pentacos-13-en-22-yl]oxy}phosphonic acid

C52H88O19P2 (1078.5394758)


PIP(PGD2/22:3(10Z,13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(PGD2/22:3(10Z,13Z,16Z)), in particular, consists of one chain of Prostaglandin D2 at the C-1 position and one chain of 10Z,13Z,16Z-docosenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:3(10Z,13Z,16Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

{[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-3-[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]-2-{[(5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid

C52H88O19P2 (1078.5394758)


PIP(22:3(10Z,13Z,16Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:3(10Z,13Z,16Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)), in particular, consists of one chain of 10Z,13Z,16Z-docosenoyl at the C-1 position and one chain of Lipoxin A4 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/22:3(10Z,13Z,16Z))

{[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-2-[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]-3-{[(5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid

C52H88O19P2 (1078.5394758)


PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/22:3(10Z,13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/22:3(10Z,13Z,16Z)), in particular, consists of one chain of Lipoxin A4 at the C-1 position and one chain of 10Z,13Z,16Z-docosenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:5(4Z,7Z,10Z,13Z,16Z)/6 keto-PGF1alpha)

{[(1S,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-6-{[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]methyl}-3,16,18,20,22,23,24-heptahydroxy-19-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,8,13-trioxo-2,4,7-trioxa-3lambda5-phosphabicyclo[13.6.3]tetracosan-21-yl]oxy}phosphonic acid

C51H84O20P2 (1078.5030924)


PIP(22:5(4Z,7Z,10Z,13Z,16Z)/6 keto-PGF1alpha) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:5(4Z,7Z,10Z,13Z,16Z)/6 keto-PGF1alpha), in particular, consists of one chain of 4Z,7Z,10Z,13Z,16Z-docosapentaenoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(6 keto-PGF1alpha/22:5(4Z,7Z,10Z,13Z,16Z))

{[(1S,6R,16S,17S,19R,20S,21R,22R,23R,24S,25R)-6-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3,17,19,21,23,24,25-heptahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,9,14-trioxo-2,4,8-trioxa-3lambda5-phosphabicyclo[14.6.3]pentacosan-22-yl]oxy}phosphonic acid

C51H84O20P2 (1078.5030924)


PIP(6 keto-PGF1alpha/22:5(4Z,7Z,10Z,13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(6 keto-PGF1alpha/22:5(4Z,7Z,10Z,13Z,16Z)), in particular, consists of one chain of 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of 4Z,7Z,10Z,13Z,16Z-docosapentaenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:5(4Z,7Z,10Z,13Z,16Z)/TXB2)

{[(1S,6R,12Z,15S,16S,20R,21R,22R,23R,24S,25R)-6-{[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]methyl}-3,16,18,21,23,24,25-heptahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,8-dioxo-2,4,7,19-tetraoxa-3lambda5-phosphabicyclo[13.7.3]pentacos-12-en-22-yl]oxy}phosphonic acid

C51H84O20P2 (1078.5030924)


PIP(22:5(4Z,7Z,10Z,13Z,16Z)/TXB2) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:5(4Z,7Z,10Z,13Z,16Z)/TXB2), in particular, consists of one chain of 4Z,7Z,10Z,13Z,16Z-docosapentaenoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(TXB2/22:5(4Z,7Z,10Z,13Z,16Z))

{[(1S,6R,13Z,16S,17S,21R,22R,23R,24R,25S,26R)-6-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3,17,19,22,24,25,26-heptahydroxy-21-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,9-dioxo-2,4,8,20-tetraoxa-3lambda5-phosphabicyclo[14.7.3]hexacos-13-en-23-yl]oxy}phosphonic acid

C51H84O20P2 (1078.5030924)


PIP(TXB2/22:5(4Z,7Z,10Z,13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(TXB2/22:5(4Z,7Z,10Z,13Z,16Z)), in particular, consists of one chain of Thromboxane B2 at the C-1 position and one chain of 4Z,7Z,10Z,13Z,16Z-docosapentaenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:5(7Z,10Z,13Z,16Z,19Z)/6 keto-PGF1alpha)

{[(1S,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-6-{[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]methyl}-3,16,18,20,22,23,24-heptahydroxy-19-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,8,13-trioxo-2,4,7-trioxa-3lambda5-phosphabicyclo[13.6.3]tetracosan-21-yl]oxy}phosphonic acid

C51H84O20P2 (1078.5030924)


PIP(22:5(7Z,10Z,13Z,16Z,19Z)/6 keto-PGF1alpha) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:5(7Z,10Z,13Z,16Z,19Z)/6 keto-PGF1alpha), in particular, consists of one chain of 7Z,10Z,13Z,16Z,19Z-docosapentaenoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(6 keto-PGF1alpha/22:5(7Z,10Z,13Z,16Z,19Z))

{[(1S,6R,16S,17S,19R,20S,21R,22R,23R,24S,25R)-6-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]-3,17,19,21,23,24,25-heptahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,9,14-trioxo-2,4,8-trioxa-3lambda5-phosphabicyclo[14.6.3]pentacosan-22-yl]oxy}phosphonic acid

C51H84O20P2 (1078.5030924)


PIP(6 keto-PGF1alpha/22:5(7Z,10Z,13Z,16Z,19Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(6 keto-PGF1alpha/22:5(7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of 7Z,10Z,13Z,16Z,19Z-docosapentaenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:5(7Z,10Z,13Z,16Z,19Z)/TXB2)

{[(1S,6R,12Z,15S,16S,20R,21R,22R,23R,24S,25R)-6-{[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]methyl}-3,16,18,21,23,24,25-heptahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,8-dioxo-2,4,7,19-tetraoxa-3lambda5-phosphabicyclo[13.7.3]pentacos-12-en-22-yl]oxy}phosphonic acid

C51H84O20P2 (1078.5030924)


PIP(22:5(7Z,10Z,13Z,16Z,19Z)/TXB2) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:5(7Z,10Z,13Z,16Z,19Z)/TXB2), in particular, consists of one chain of 7Z,10Z,13Z,16Z,19Z-docosapentaenoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(TXB2/22:5(7Z,10Z,13Z,16Z,19Z))

{[(1S,6R,13Z,16S,17S,21R,22R,23R,24R,25S,26R)-6-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]-3,17,19,22,24,25,26-heptahydroxy-21-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3,9-dioxo-2,4,8,20-tetraoxa-3lambda5-phosphabicyclo[14.7.3]hexacos-13-en-23-yl]oxy}phosphonic acid

C51H84O20P2 (1078.5030924)


PIP(TXB2/22:5(7Z,10Z,13Z,16Z,19Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(TXB2/22:5(7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of Thromboxane B2 at the C-1 position and one chain of 7Z,10Z,13Z,16Z,19Z-docosapentaenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

Tuberoside F

2-[(4-hydroxy-6-{[(6Z)-15-hydroxy-7-methoxy-7,9,13-trimethyl-6-(3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butylidene)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-16-yl]oxy}-2-(hydroxymethyl)-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C52H86O23 (1078.5559606000002)


Tuberoside f is a member of the class of compounds known as steroidal glycosides. Steroidal glycosides are sterol lipids containing a carbohydrate moiety glycosidically linked to the steroid skeleton. Tuberoside f is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Tuberoside f can be found in potato, which makes tuberoside f a potential biomarker for the consumption of this food product.

   

Terrestrosin K

(1R,2S,4S,8R,9S,12S,13S,16S,18S)-16-[(2R,3R,4R,5R,6R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-6-en-10-one

C51H82O24 (1078.5195772000002)


   

Methylprotogracillin

(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-2-[[(1S,2S,4S,6R,7S,8R,9S,12S,13R,16S)-6-methoxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-16-yl]oxy]-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol

C52H86O23 (1078.5559606000002)


(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-2-[[(1S,2S,4S,6R,7S,8R,9S,12S,13R,16S)-6-methoxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-16-yl]oxy]-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol is a natural product found in Dracaena draco, Dracaena concinna, and other organisms with data available. Methyl protogracillin (NSC-698793), isolated from the roots of Dioscorea opposite Thunb, exhibits strong anti-cancer activity[1]. Methyl protogracillin (NSC-698793), isolated from the roots of Dioscorea opposite Thunb, exhibits strong anti-cancer activity[1].

   

Terrestrosin

(1R,2S,4S,8R,9S,12S,13S,16S,18S)-16-[(2R,3R,4R,5R,6R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-6-en-10-one

C51H82O24 (1078.5195772000002)


   

Pneumocandin A0

Pneumocandin A0

C51H82N8O17 (1078.5797642)


D000890 - Anti-Infective Agents > D000935 - Antifungal Agents > D054714 - Echinocandins

   

methyl protogracillin

(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-2-[[(1S,2S,4S,6R,7S,8R,9S,12S,13R,16S)-6-methoxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-16-yl]oxy]-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol

C52H86O23 (1078.5559606000002)


(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-2-[[(1S,2S,4S,6R,7S,8R,9S,12S,13R,16S)-6-methoxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-16-yl]oxy]-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol is a natural product found in Dracaena draco, Dracaena concinna, and other organisms with data available. Methyl protogracillin (NSC-698793), isolated from the roots of Dioscorea opposite Thunb, exhibits strong anti-cancer activity[1]. Methyl protogracillin (NSC-698793), isolated from the roots of Dioscorea opposite Thunb, exhibits strong anti-cancer activity[1].

   
   
   
   
   
   
   
   

anagalligenin A 3-O-{beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranoside}|capilliposide A

anagalligenin A 3-O-{beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranoside}|capilliposide A

C52H86O23 (1078.5559606000002)


   

(25R)-26-(??-D-Glucopyranosyloxy)-22-methoxyfurost-5-en-3??-yl-O-??-L-rhamnopyranosyl-(1鈥樏傗垎2)-O-[??-D-glucopyranosyl-(1鈥樏傗垎6)]-??-D-glucopyranoside

(25R)-26-(??-D-Glucopyranosyloxy)-22-methoxyfurost-5-en-3??-yl-O-??-L-rhamnopyranosyl-(1鈥樏傗垎2)-O-[??-D-glucopyranosyl-(1鈥樏傗垎6)]-??-D-glucopyranoside

C52H86O23 (1078.5559606000002)


   
   
   

3beta-{{O-[O-[beta-D-glucopyranosyl-(1->2)]-O-[beta-D-apiofuranosyl-(1->3)]]-beta-D-glucopyranosyl-(1->2)-alpha-L-arabinopyranosyl}oxy}lotogenin|lotoside A

3beta-{{O-[O-[beta-D-glucopyranosyl-(1->2)]-O-[beta-D-apiofuranosyl-(1->3)]]-beta-D-glucopyranosyl-(1->2)-alpha-L-arabinopyranosyl}oxy}lotogenin|lotoside A

C52H86O23 (1078.5559606000002)


   

3-O-{alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranosyl}-26-O-beta-D-glucopyranosyl-22alpha-methoxy-25R-furost-5-ene-3beta,17alpha,26-triol|lycianthoside A

3-O-{alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranosyl}-26-O-beta-D-glucopyranosyl-22alpha-methoxy-25R-furost-5-ene-3beta,17alpha,26-triol|lycianthoside A

C52H86O23 (1078.5559606000002)


   

26-O-beta-D-glucopyranosyl-(25S,20R)-20-O-methyl-5alpha-furost-22(23)-en-2alpha,3beta,20,26-tetraol 3-O-alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranoside|tuberoside F

26-O-beta-D-glucopyranosyl-(25S,20R)-20-O-methyl-5alpha-furost-22(23)-en-2alpha,3beta,20,26-tetraol 3-O-alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranoside|tuberoside F

C52H86O23 (1078.5559606000002)


   

6-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-4-C-[({[6-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy )pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-4-(chloromethyl)-4-hydroxytetrahydro-2H-pyran-2-yl]acetyl}oxy)methyl]-1-deoxyhex-2-ulopyranose

6-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-4-C-[({[6-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy )pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-4-(chloromethyl)-4-hydroxytetrahydro-2H-pyran-2-yl]acetyl}oxy)methyl]-1-deoxyhex-2-ulopyranose

C55H83ClN2O17 (1078.5379978)


   

3-O-beta-D-xylopyranosyl(1->3)-[beta-D-galactopyranosyl(1->2)]-beta-D-methylglucuronopyranosyl-22-O-benzoylbarringtogenol C

3-O-beta-D-xylopyranosyl(1->3)-[beta-D-galactopyranosyl(1->2)]-beta-D-methylglucuronopyranosyl-22-O-benzoylbarringtogenol C

C55H82O21 (1078.5348322)


   

19-Oxo-3??,20S,21-trihydroxy-25-hydroperoxydammar-23-ene 3-O-{[??-L-rhamnopyranosyl(1鈥樏傗垎2)][??-D-xylopyranosyl(1鈥樏傗垎3)]-??-L-arabinopyranosyl}-21-O-??-D-glucopyranoside

19-Oxo-3??,20S,21-trihydroxy-25-hydroperoxydammar-23-ene 3-O-{[??-L-rhamnopyranosyl(1鈥樏傗垎2)][??-D-xylopyranosyl(1鈥樏傗垎3)]-??-L-arabinopyranosyl}-21-O-??-D-glucopyranoside

C52H86O23 (1078.5559606000002)


   

(25S)-Spirost-5-ene-3beta,17alpha,27-triol 3-O-alpha-L-rhamnopyranosyl-(1->2)-O-2)-O-beta-D-glucopyranosyl-(1->4)>-beta-D-glucopyranoside|(25S)-Spirost-5-ene-3beta,17alpha,27-triol 3-O-alpha-L-rhamnopyranosyl-(1->2)-O-[beta-D-glucopyranosyl-(1->2)-O-beta-D-glucopyranosyl-(1->4)]-beta-D-glucopyranoside

(25S)-Spirost-5-ene-3beta,17alpha,27-triol 3-O-alpha-L-rhamnopyranosyl-(1->2)-O-2)-O-beta-D-glucopyranosyl-(1->4)>-beta-D-glucopyranoside|(25S)-Spirost-5-ene-3beta,17alpha,27-triol 3-O-alpha-L-rhamnopyranosyl-(1->2)-O-[beta-D-glucopyranosyl-(1->2)-O-beta-D-glucopyranosyl-(1->4)]-beta-D-glucopyranoside

C51H82O24 (1078.5195772000002)


   

(25R)-26-[(??-L-Rhamnopyranosyl)oxy]-22??-methoxyfurost-5-en-3??-yl-O-??-D-glucopyranosyl-(1鈥樏傗垎3)-O-??-D-glucopyranosyl-(1鈥樏傗垎3)-O-??-D-glucopyranoside

(25R)-26-[(??-L-Rhamnopyranosyl)oxy]-22??-methoxyfurost-5-en-3??-yl-O-??-D-glucopyranosyl-(1鈥樏傗垎3)-O-??-D-glucopyranosyl-(1鈥樏傗垎3)-O-??-D-glucopyranoside

C52H86O23 (1078.5559606000002)


   

(25R)-O-beta-D-glucopyranosyl-22-O-methylfurost-5-ene-3beta,22xi,26-triol 3-O-2)-O-4)>-beta-D-glucopyranoside>|22-O-methyl-26-O-beta-D-glucopyranosyl-(25R)-furost-5-ene-3beta,22xi,26-triol 3-O--beta-D-glucopyranoside>|26-O-beta-D-glucopyranosyl-22-O-methylfurost-5-ene-3beta,26-diol 3-O-2)>-4)>-beta-D-glucopyranoside|26-O-beta-D-glucopyranosyl-22-O-methylfurost-5-ene-3beta,26-diol 3-O-[alpha-L-rhamnopyranosyl(1[*]2)]-[beta-D-glucopyranosyl(1[*]4)]-beta-D-glucopyranoside|methyl proto-deltonin

(25R)-O-beta-D-glucopyranosyl-22-O-methylfurost-5-ene-3beta,22xi,26-triol 3-O-2)-O-4)>-beta-D-glucopyranoside>|22-O-methyl-26-O-beta-D-glucopyranosyl-(25R)-furost-5-ene-3beta,22xi,26-triol 3-O--beta-D-glucopyranoside>|26-O-beta-D-glucopyranosyl-22-O-methylfurost-5-ene-3beta,26-diol 3-O-2)>-4)>-beta-D-glucopyranoside|26-O-beta-D-glucopyranosyl-22-O-methylfurost-5-ene-3beta,26-diol 3-O-[alpha-L-rhamnopyranosyl(1[*]2)]-[beta-D-glucopyranosyl(1[*]4)]-beta-D-glucopyranoside|methyl proto-deltonin

C52H86O23 (1078.5559606000002)


   

(25R)-26-[(beta-D-glucopyranosyl)oxy]-1alpha-hydroxy-22alpha-methoxyfurost-5-en-3beta-yl O-alpha-L-rhamnopyranosyl-(1->2)-[O-alpha-L-rhamnopyranosyl(1->4)]-beta-D-glucopyranoside

(25R)-26-[(beta-D-glucopyranosyl)oxy]-1alpha-hydroxy-22alpha-methoxyfurost-5-en-3beta-yl O-alpha-L-rhamnopyranosyl-(1->2)-[O-alpha-L-rhamnopyranosyl(1->4)]-beta-D-glucopyranoside

C52H86O23 (1078.5559606000002)


   
   

(25R)-26-O-beta-D-glucopyranosyl-5,20-dienefurostan-2alpha,3beta,26-triol-3-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|fistulosaponin E

(25R)-26-O-beta-D-glucopyranosyl-5,20-dienefurostan-2alpha,3beta,26-triol-3-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|fistulosaponin E

C51H82O24 (1078.5195772000002)


   

(25R)-3beta-[(O-beta-D-glucopyranosyl-(1->2)-O-[beta-D-glucopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranosyl)oxy]-5alpha-spirostan-12-one

(25R)-3beta-[(O-beta-D-glucopyranosyl-(1->2)-O-[beta-D-glucopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranosyl)oxy]-5alpha-spirostan-12-one

C51H82O24 (1078.5195772000002)


   
   
   

N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-2-carbamoyl-1-hydroxyethyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosan-18-yl]-10,12-dimethyltetradecanamide

N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-2-carbamoyl-1-hydroxyethyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosan-18-yl]-10,12-dimethyltetradecanamide

C51H82N8O17 (1078.5797642)


   

[IIN-based: Match]

NCGC00347717-02! [IIN-based: Match]

C51H82N8O17 (1078.5797642)


   

M-Secociguatoxin 4A

16-[(1Z)-buta-1,3-dien-1-yl]-45-(3-hydroxypropyl)-43,44,49,54,58-pentamethyl-2,7,11,17,21,26,33,37,41,46,51,57-dodecaoxadodecacyclo[30.28.0.0^{3,27}.0^{6,25}.0^{8,22}.0^{10,20}.0^{12,18}.0^{34,58}.0^{36,56}.0^{38,52}.0^{40,50}.0^{42,47}]hexaconta-4,14,23,29-tetraene-19,45,48,59-tetrol

C60H86O17 (1078.5864706)


   

Arenaroside A

3-O-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-2)-beta-d-glucopyranosyl-(1-4)]-alpha-l-arabinopyranosyl-3beta,15alpha,16alpha,22alpha,28-pentahydroxyolean-12-ene

C52H86O23 (1078.5559606000002)


   

N-{(6S,9R,14aS,20S,23S,25aS)-20-[(1S)-3-Amino-1-hydroxy-3-oxopropyl]-23-[(1R)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6-[(1S)-1-hydroxyethyl]-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2,1-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide

N-{(6S,9R,14aS,20S,23S,25aS)-20-[(1S)-3-Amino-1-hydroxy-3-oxopropyl]-23-[(1R)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6-[(1S)-1-hydroxyethyl]-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2,1-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide

C51H82N8O17 (1078.5797642)


   
   
   
   

2-[O-(beta-D-glucopyranosyl)]-tylosin

2-[O-(beta-D-glucopyranosyl)]-tylosin

C52H88NO22+ (1078.5797688)


   

2-[4-hydroxy-6-[[(6Z)-15-hydroxy-7-methoxy-7,9,13-trimethyl-6-[3-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutylidene]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-16-yl]oxy]-2-(hydroxymethyl)-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol

2-[4-hydroxy-6-[[(6Z)-15-hydroxy-7-methoxy-7,9,13-trimethyl-6-[3-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutylidene]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-16-yl]oxy]-2-(hydroxymethyl)-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol

C52H86O23 (1078.5559606000002)


   

PIP(22:3(10Z,13Z,16Z)/PGE2)

PIP(22:3(10Z,13Z,16Z)/PGE2)

C52H88O19P2 (1078.5394758)


   

PIP(PGE2/22:3(10Z,13Z,16Z))

PIP(PGE2/22:3(10Z,13Z,16Z))

C52H88O19P2 (1078.5394758)


   

PIP(22:3(10Z,13Z,16Z)/PGD2)

PIP(22:3(10Z,13Z,16Z)/PGD2)

C52H88O19P2 (1078.5394758)


   

PIP(PGD2/22:3(10Z,13Z,16Z))

PIP(PGD2/22:3(10Z,13Z,16Z))

C52H88O19P2 (1078.5394758)


   

PIP(22:5(4Z,7Z,10Z,13Z,16Z)/TXB2)

PIP(22:5(4Z,7Z,10Z,13Z,16Z)/TXB2)

C51H84O20P2 (1078.5030924)


   

PIP(TXB2/22:5(4Z,7Z,10Z,13Z,16Z))

PIP(TXB2/22:5(4Z,7Z,10Z,13Z,16Z))

C51H84O20P2 (1078.5030924)


   

PIP(22:5(7Z,10Z,13Z,16Z,19Z)/TXB2)

PIP(22:5(7Z,10Z,13Z,16Z,19Z)/TXB2)

C51H84O20P2 (1078.5030924)


   

PIP(TXB2/22:5(7Z,10Z,13Z,16Z,19Z))

PIP(TXB2/22:5(7Z,10Z,13Z,16Z,19Z))

C51H84O20P2 (1078.5030924)


   

PIP(22:5(4Z,7Z,10Z,13Z,16Z)/6 keto-PGF1alpha)

PIP(22:5(4Z,7Z,10Z,13Z,16Z)/6 keto-PGF1alpha)

C51H84O20P2 (1078.5030924)


   

PIP(6 keto-PGF1alpha/22:5(4Z,7Z,10Z,13Z,16Z))

PIP(6 keto-PGF1alpha/22:5(4Z,7Z,10Z,13Z,16Z))

C51H84O20P2 (1078.5030924)


   

PIP(22:5(7Z,10Z,13Z,16Z,19Z)/6 keto-PGF1alpha)

PIP(22:5(7Z,10Z,13Z,16Z,19Z)/6 keto-PGF1alpha)

C51H84O20P2 (1078.5030924)


   

PIP(6 keto-PGF1alpha/22:5(7Z,10Z,13Z,16Z,19Z))

PIP(6 keto-PGF1alpha/22:5(7Z,10Z,13Z,16Z,19Z))

C51H84O20P2 (1078.5030924)


   

PIP(22:3(10Z,13Z,16Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

PIP(22:3(10Z,13Z,16Z)/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C52H88O19P2 (1078.5394758)


   

PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/22:3(10Z,13Z,16Z))

PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/22:3(10Z,13Z,16Z))

C52H88O19P2 (1078.5394758)